Viewing Study NCT03208335


Ignite Creation Date: 2025-12-24 @ 10:12 PM
Ignite Modification Date: 2025-12-30 @ 7:14 AM
Study NCT ID: NCT03208335
Status: UNKNOWN
Last Update Posted: 2017-07-05
First Post: 2017-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module